Shiyi Shao

79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Antigen Spreading via Localized Administration Enhances Adoptive TCR-T Cell Therapy in Pancreatic Cancer.

Antigen Spreading via Localized Administration Enhances Adoptive TCR-T Cell Therapy in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 15, 2026

Correction: Tumor-triggered personalized microRNA cocktail therapy for hepatocellular carcinoma.

Correction: Tumor-triggered personalized microRNA cocktail therapy for hepatocellular carcinoma.

Journal: Biomaterials science

Published: March 10, 2026

Macrophage-specific in vivo RNA editing promotes phagocytosis and antitumor immunity in mice.

Macrophage-specific in vivo RNA editing promotes phagocytosis and antitumor immunity in mice.

Journal: Science translational medicine

Published: January 15, 2025

Correction: Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy.

Correction: Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy.

Journal: Journal of nanobiotechnology

Published: January 03, 2025

STING-activating pyroptotic nanoparticles for in situ pancreatic cancer vaccination and immunotherapy.

STING-activating pyroptotic nanoparticles for in situ pancreatic cancer vaccination and immunotherapy.

Journal: Science bulletin

Published: November 08, 2024

Engineered a Gemcitabine Nano-Prodrug Targeting Desmoplastic Pancreatic Tumor with Dual Enhancement of Penetration Dynamics.

Engineered a Gemcitabine Nano-Prodrug Targeting Desmoplastic Pancreatic Tumor with Dual Enhancement of Penetration Dynamics.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: November 08, 2024

In Situ Formed ROS-Responsive Hydrogel with STING Agonist and Gemcitabine to Intensify Immunotherapy against Pancreatic Ductal Adenocarcinoma.

In Situ Formed ROS-Responsive Hydrogel with STING Agonist and Gemcitabine to Intensify Immunotherapy against Pancreatic Ductal Adenocarcinoma.

Journal: Advanced healthcare materials

Published: December 15, 2022

An Ionic Liquid Ablation Agent for Local Ablation and Immune Activation in Pancreatic Cancer.

An Ionic Liquid Ablation Agent for Local Ablation and Immune Activation in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 21, 2022

A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors.

A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: August 23, 2022

Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer.

Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 18, 2022

Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy.

Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy.

Journal: Journal of nanobiotechnology

Published: December 12, 2021

Gallbladder Adenosquamous Cancer with Situs Inversus Totalis: A Case Report and Literature Review.

Gallbladder Adenosquamous Cancer with Situs Inversus Totalis: A Case Report and Literature Review.

Journal: OncoTargets and therapy

Published: May 07, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026